Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Staphylococcal Infections
Interventions
DRUG

Vancomycin

Randomized double-blind equivalence trial to test the hypothesis that 2 days is equivalent to 7 days of vancomycin treatment for intravascular device associated bacteremia due to coagulase negative staphylococcus. The definitions for the surveillance of intravascular device associated bacteremia from the Laboratory Centre for Disease Control-Health Canada will be used. Surveillance blood cultures on days 4 and 9 following removal of intravascular device. Relatedness of strains will be determined by pulsed-field gel electrophoresis (PFGE).

Trial Locations (1)

V5Z 1M9

Vancouver General Hospital Intensive Care Unit, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT00175370 - Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus | Biotech Hunter | Biotech Hunter